These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 607960)

  • 21. Kinetics of formation of factor IXa-factor VIII complex on the surface of platelets.
    Elödi S; Váradi K; Vörös E
    Thromb Res; 1981 Mar; 21(6):695-700. PubMed ID: 6791301
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelets and coagulation proteins.
    Walsh PN
    Fed Proc; 1981 May; 40(7):2086-91. PubMed ID: 6785110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation assays and platelet aggregation patterns in human, baboon, and canine blood.
    Feingold HM; Pivacek LE; Melaragno AJ; Valeri CR
    Am J Vet Res; 1986 Oct; 47(10):2197-9. PubMed ID: 3096173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation factor activity in platelet concentrates.
    Simon TL; Henderson R
    Transfusion; 1979; 19(2):186-9. PubMed ID: 432931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preservation of blood platelets concentrates at different temperatures].
    León G; Soré A; Linares J; Campo-Aasen I; Carmona O
    Acta Cient Venez; 1990; 41(1):43-9. PubMed ID: 2135557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and "in vitro" functions of platelets stored as platelet concentrates at room temperature.
    Balduini CL; Sinigaglia F; Grignani G; Bisio A; Rota Scalabrini D; Mazzucco M; Pacchiarini L; Balduini C
    Haematologica; 1986; 71(3):177-82. PubMed ID: 3093319
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of human factor VIII. II. Characterization of forms of factor VIII binding to platelets in the presence of ristocetin.
    Doucet-de Bruïne MH; Sixma JJ; Over J; Beeser-Visser NH
    J Lab Clin Med; 1978 Jul; 92(1):96-107. PubMed ID: 659967
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations on the heparin neutralizing activity of outdated platelet concentrates.
    Griffiths BL; Collins JR; Huntsman RG
    Thromb Haemost; 1984 Apr; 51(2):189-91. PubMed ID: 6740551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cardiac operation on platelets.
    Mohr R; Golan M; Martinowitz U; Rosner E; Goor DA; Ramot B
    J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 1):434-41. PubMed ID: 3091948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in the physiopathology of the platelet membrane].
    Ruan C; Kieffer N; Tobelem G
    Sem Hop; 1982 Nov; 58(41):2419-22. PubMed ID: 6297031
    [No Abstract]   [Full Text] [Related]  

  • 34. Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. I. Effect of neuraminidase.
    Levy-Toledano S; Caen JP; Halmos T; Mester L
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:60-2. PubMed ID: 4587019
    [No Abstract]   [Full Text] [Related]  

  • 35. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G; Drouet L; Caen J
    Nouv Presse Med; 1980 Mar; 9(13):949-54. PubMed ID: 6987618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation of human platelets from plasma proteins including factor VIII VWF by a combined albumin gradient-gel filtration method using HEPES buffer.
    Timmons S; Hawiger J
    Thromb Res; 1978 Feb; 12(2):297-306. PubMed ID: 635845
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet function and factor VIII in uremia.
    Park HS; Kim MW; Kim TJ; Hwang SD; Lee HB
    Korean J Intern Med; 1987 Jan; 2(1):74-8. PubMed ID: 3155324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible relationship between alterations in platelet function, factor VIII, and the accelerated atherosclerosis seen in heart transplant patients.
    Harbury CB
    Scand J Haematol Suppl; 1979; 34():119-24. PubMed ID: 384505
    [No Abstract]   [Full Text] [Related]  

  • 40. Altered properties of phospholipid-bound factor VIII.
    Elödi S; Váradi K
    Thromb Res; 1984 Mar; 33(5):557-9. PubMed ID: 6426083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.